奥明格健脑口服液改善小鼠记忆的作用

目的观察奥明格健脑口服液对改善小鼠记忆作用的影响。方法断乳小鼠，体重１２～１４ｇ，每组１４～１６只。把实验动物随机分为正常对照组、高剂量组、中剂量组和低剂量组，连续给样３０ｄ，进行跳台和水迷宫试验，以上试验按同样方法重复一次。结果两次小鼠实验表明，灌胃奥明格健脑口服液１ｍｏ后，跳台试验中受电击动物数和错误总数，各试验组均低于对照组，其中高剂量试验组显著低于对照组，而且潜伏期显著延长。水迷宫试验中，动物到达终点所需时间和错误总数，高中剂量组试验组均显著低于对照组。结论奥明格健脑口服液具有改善动物记忆的作用。     

Views about integrating smoking cessation treatment within psychological services for patients with common mental illness: A multi‐perspective qualitative study

BackgroundTobacco smoking rates are significantly higher in people with common mental illness compared to those without. Smoking cessation treatment could be offered as part of usual outpatient psychological care, but currently is not.ObjectiveTo understand patient and health care professionals'' views about integrating smoking cessation treatment into outpatient psychological services for common mental illness.DesignQualitative in‐depth interviews, with thematic analysis.ParticipantsEleven Improving Access to Psychological Therapies (IAPT) psychological wellbeing practitioners (PWPs), six IAPT patients, and six stop smoking advisors were recruited from English smoking cessation, and IAPT services.ResultsPatients reported psychological benefits from smoking, and also described smoking as a form of self‐harm. Stop smoking advisors displayed therapeutic pessimism and stigmatizing attitudes towards helping people with mental illness to quit smoking. PWPs have positive attitudes towards smoking cessation treatment for people with common mental illness. PWPs and patients accept evidence that smoking tobacco may harm mental health, and quitting might benefit mental health. PWPs report expertise in helping people with common mental illness to make behavioural changes in the face of mood disturbances and low motivation. PWPs felt confident in offering smoking cessation treatments to patients, but suggested a caseload reduction may be required to deliver smoking cessation support in IAPT.ConclusionsIAPT appears to be a natural environment for smoking cessation treatment. PWPs may need additional training, and a caseload reduction. Integration of smoking cessation treatment into IAPT services should be tested in a pilot and feasibility study.Patient or public contributionService users and members of the public were involved in study design and interpretation of data.     

辨证掌握穴位注射方法提高穴位注射的疗效

目的:提高中西结合治疗疾病的疗效.方法:在中医辨证的基础上,在腧穴上进行针剂注射.结果:通过针刺和药液渗透,将穴位疗效和药理作用结合在一起,充分发挥其综合效能.结论:用中医辨证理论,穴位注射治疗能疏通经络,调补阴阳.针药结合,提高疗效.     

贯彻"三个代表"重要思想提高7年制学生思想政治工作质效

思想政治工作是我国高等教育的生命线,如何提高思想政治工作的质效是每一位教育工作者不能不关注的重大课题.实践证明,以"三个代表"为指引,以民主管理为重点,确立学生的中心地位,树精品战略,提高学生文化素养、科技创新等能力,能够很好地提高学生思想政治工作的质效,培养出适应时代需要的高级中医人才.     

散血明目片对非缺血型视网膜静脉阻塞患者血液流变学的影响

目的探讨散血明目片对非缺血型视网膜静脉阻塞患者血液流变学及血清相关生化指标的影响及作用机制。方法将34例非缺血型视网膜静脉阻塞患者随机分为治疗组（17例17眼）与对照组（17例18眼）,治疗组口服散血明目片,对照组口服血栓通片,两组均同时配合其他中西医常规治疗方法。治疗2个月后比较两组临床疗效、血液流变学及血清相关生化指标的差异。结果治疗组总显效率与对照组比较,差异有显著统计学意义（P〈0.01）;治疗组治疗前后低切和高切全血比黏度、红细胞电泳、血浆黏度、红细胞聚集指数、AT-Ⅲ、lp（a）、NO、A-CL IgG阳性率、ACL IgM阳性率、LA阳性率差异有显著统计学意义（P〈0.01）;ET-1、ACL IgA阳性率差异有统计学意义（P〈0.05）。结论散血明目片是治疗非缺血型视网膜静脉阻塞的有效药物,其作用机制可能与升高AT-Ⅲ、降低lp（a）、APL在血浆中的含量、稳定ET-1/NO比值有关,在外可反映于血液流变学指标的变化。     

四逆散冻干粉改善大鼠睡眠作用机制研究

目的研究四逆散冻干粉改善大鼠睡眠作用机制。方法按照随机数表法将SD雄性大鼠随机分为5组:空白对照组、阴性对照组、阳性对照组、四逆散冻干粉组,混合物组,每组10只。阴性对照组的大鼠灌胃0. 9%Na Cl;阳性对照组的大鼠灌胃盐酸帕罗西汀溶液4. 2 mg·kg^-1;四逆散冻干粉组的大鼠灌胃四逆散冻干粉水煎液2. 41 g·kg^-1;混合物组灌胃混合物(辛弗林-芍药苷-柴胡皂苷C-甘草次酸=8. 5∶1. 0∶1. 5∶6. 5) 206 mg·kg^-1。每日灌胃1次,连续给药1周。用高效液相色谱(HPLC)法测定脑脊液移行成分。结果四逆散冻干粉在脑脊液中除戊巴比妥钠成分外,并无血中移行成分的进入;给予四逆散冻干粉后,脑脊液中成分峰面积约是空白脑脊液峰面积的12. 5倍;血清中四逆散的移行成分(辛弗林、芍药苷、柴胡皂苷C、甘草次酸)均可以使脑脊液中该内源性物质峰面积高于空白脑脊液峰面积,但不如四逆散整方作用;混和物组增高脑脊液中内源性物质峰面积是四逆散组的3. 2倍,该内源性物质是5-羟色胺。结论四逆散冻干粉是通过促进脑脊液中内源性物质5-羟色胺的分泌达到改善睡眠作用的。     

Elevating your breast program to the next level

This paper describes a series of steps taken to elevate the Hoag Breast Program to the next level. The hope is that some of our ideas will be useful to you and your breast program.     

住院患者退药现象分析及改进方法

目的了解患者退药的具体原因,有针对性地实行应对措施,以减少退药现象。方法采用回顾性研究方法,对医院2013年7月25日至8月10日收治的495例住院患者退药单的退药情况进行统计及分析。结果日平均退药率为2.20%,退药原因为出院（43.64%）,调整用药（17.98%）,医生原因（10.91%）,手术原因（9.90%）;退药较多的科室为普外科、妇产科、骨科、中医科,分别占10.30%,8.89%,8.08%,8.08%;退药种类中营养及补液类药物最多（28.31%）,其次为抗感染药物（20.48%）。结论退药现象由医院信息管理系统、医生、患者等多方面因素造成,只有医患共同努力,医院提高信息技术水平,才能减少退药情况的发生,提高医疗服务质量。     

缺血预处理对兔脊髓缺血损伤后的保护作用及其机制

目的:探讨缺血预处理对兔脊髓缺血损伤的保护作用及机制。方法:24只雄性新西兰大白兔随机数字表法分3组(每组8只):即缺血组(IC组)、缺血预处理组(IPC组)及假手术组(S组)。IC组夹闭兔腹主动脉肾下段20min,制作兔脊髓缺血模型;IPC组预先使脊髓缺血6min,再灌注30min后再次阻闭兔腹主动脉肾下段20min;S组除不夹闭腹主动脉外,其余处理同IC组。再灌注后8,12,24和48h分别对动物神经功能评分;再灌注后48h,测定血浆血栓素B2(TXB2,TXA2的稳定代谢产物)的含量及6-酮前列素(6-keto-PGF1α,PGI2的稳定代谢产物)的含量,然后处死动物取脊髓,测定脊髓组织中TXB2及6-keto-PGF1α的含量。结果:IPC组神经功能评分各时间点均明显高于IC组。与IC组相比,IPC组血浆和脊髓中TXB2含量明显减少,分别为(108±20)mg/L,(733±64)ng/g(P<0.05,F=27.93,132.887),而IPC组血浆和脊髓中6-keto-PGF1α含量明显增多,分别为(75±14)mg/L,(502±37)ng/g(P<0.05,F=13.185,64.141)。IPC组血浆和脊髓中TXB2/6-keto-PGF1α分别为(1.45±0.17),(1.47±0.19),明显低于IC组(P<0.05,F=20.83,29.447)。结论:缺血预处理对脊髓缺血损伤有显著的保护作用,保护机制与缺血预处理改善脊髓缺血损伤后TXA2-PGI2平衡失调有关。